Search

Your search keyword '"Abbasi, Laleh"' showing total 14 results
Start Over Author "Abbasi, Laleh" Publication Year Range Last 10 years
14 results on '"Abbasi, Laleh"'

9. Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori

Author

Seyyedmajidi, Mohammadreza, Abbasi, Laleh, Seyyedmajidi, Seyedali, Hosseini, Seyed Ashkan, Ahmadi, Anahita, Hajiebrahimi, Shahin, and Vafaeimanesh, Jamshi

Subjects
Bismuth-based quadruple therapy, lcsh:Internal medicine, Helicobacter pylori, Second-line Therapy, Bismuth Sub-Citrate, Furazolidone, Amoxicillin, Original Article, Levofloxacin-based triple therapy, Levofloxacin, lcsh:RC31-1245
Abstract

Background: Although the prevalence of Helicobacter pylori infection decreased following the hygiene promotion and application of proper anti- H.pylori treatments, unfortunately gradual increase is reported in treatment failure; hence, application of a proper treatment regimen as a second-line therapy is of great importance. Methods: In the current randomized, clinical trial, a total of 120 patients with peptic ulcers who failed to respond to treatment were enrolled. In the OLA group, a regimen of omeprazole 40 mg/day, levofloxacin 1 g/day, and amoxicillin 2 g/ day was prescribed; however, a regimen of omeprazole 40 mg/day, bismuth sub-citrate 480 mg/day, furazolidone 400 mg/day, and amoxicillin 2 g/day was administered to the OFAB group. Both groups were treated for 2 weeks, and 6 weeks after the treatment, the urea breath test (UBT) was performed in the subjects. Collected data were analyzed with SPSS Version 18. At the end, 58 patients in group OLA and 57 patients in the OFAB group were analyzed. Results: According to the results of the current study, 96.7 of the subjects in the OLA and 95 in the OFAB groups completed the treatment course and the eradication rates were 86.7 and 78.3 in the OLA and OFAB groups, respectively (P=0.23). Treatment side effects were observed in 51.7 and 11.7 of the subjects in the OLA and OFAB groups, respectively (P

Published
2019

10. 3D‐Printed Hydrogel‐Filled Microneedle Arrays

Author

Barnum, Lindsay, primary, Quint, Jacob, additional, Derakhshandeh, Hossein, additional, Samandari, Mohamadmahdi, additional, Aghabaglou, Fariba, additional, Farzin, Ali, additional, Abbasi, Laleh, additional, Bencherif, Sidi, additional, Memic, Adnan, additional, Mostafalu, Pooria, additional, and Tamayol, Ali, additional

Published
2021
Full Text
View/download PDF

11. In Vivo Printing of Nanoenabled Scaffolds for the Treatment of Skeletal Muscle Injuries

Author

Quint, Jacob P., primary, Mostafavi, Azadeh, additional, Endo, Yori, additional, Panayi, Adriana, additional, Russell, Carina S., additional, Nourmahnad, Atousa, additional, Wiseman, Chris, additional, Abbasi, Laleh, additional, Samandari, Mohamadmahdi, additional, Sheikhi, Amir, additional, Nuutila, Kristo, additional, Sinha, Indranil, additional, and Tamayol, Ali, additional

Published
2021
Full Text
View/download PDF

14. A Review on Role of Inflammation in Coronavirus Disease.

Author

Lotfi A, Hajian P, Abbasi L, Gargari MK, Fard NNG, and Naderi D

Subjects
Humans, Signal Transduction, Animals, COVID-19 immunology, COVID-19 complications, Inflammation immunology, Cytokine Release Syndrome immunology, Cytokine Release Syndrome etiology, Cytokines metabolism, Cytokines immunology, SARS-CoV-2 immunology, SARS-CoV-2 pathogenicity
Abstract

The respiratory illness known as COVID-19 is caused by the novel coronavirus, SARS-CoV-2. While the precise pathogenic mechanism of COVID-19 remains unclear, the occurrence of a cytokine storm subsequent to viral infection plays a pivotal role in the initiation and advancement of the disease. The infection of SARS-CoV-2 induces a state of immune system hyperactivity, leading to an excessive production of inflammatory cytokines. Consequently, the identification of the various signaling pathways implicated in the inflammation induced by COVID-19 will enable researchers to investigate new targets for therapeutic intervention., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results